Evidence map›Paper›PMID 28407060›Full record

ArticleEndocrinology2017

Role of Osteoblast Gi Signaling in Age-Related Bone Loss in Female Mice.

Susan M Millard, Liping Wang, Lalita Wattanachanya, Dylan O'Carroll, Aaron J Fields, Joyce Pang, Galateia Kazakia, Jeffrey C Lotz, Robert A Nissenson

Open access · hybridAbstract read
In one paragraph

Article in Endocrinology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. JBMR plus · 2024
    Article
  5. Article
  6. Bone Status in a Mouse Model of Experimental Autoimmune-Orchitis.International journal of molecular sciences · 2021
    Article
  7. Article
  8. Co-stimulation of LPARStem cell research & therapy · 2018
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Susan M MillardEndocrine Research Unit, VA Medical Center, San Francisco, California 94158.
Liping WangEndocrine Research Unit, VA Medical Center, San Francisco, California 94158.
Lalita WattanachanyaEndocrine Research Unit, VA Medical Center, San Francisco, California 94158.
Dylan O'CarrollEndocrine Research Unit, VA Medical Center, San Francisco, California 94158.
Aaron J FieldsDepartment of Orthopedic Surgery, University of California, San Francisco, California 94158.
Joyce PangDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, California 94143.
Galateia KazakiaDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, California 94143.
Jeffrey C LotzDepartment of Orthopedic Surgery, University of California, San Francisco, California 94158.
Robert A NissensonEndocrine Research Unit, VA Medical Center, San Francisco, California 94158.
University of California, San Francisco · USSan Francisco VA Medical Center · US

Funding

UCSF Core Center for Musculoskeletal Biology and MedicineP30AR066262 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MAJUMDAR, SHARMILA · 2014 to 2018
$3.0M
G PROTEIN SIGNALING IN OSTEOBLASTSR01DK072071 · NIDDK · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI NISSENSON, ROBERT · 2006 to 2009
$1.3M
G Protein Signaling in OsteoblastsI01BX001496 · VA · VETERANS AFFAIRS MED CTR SAN FRANCISCO · PI NISSENSON, ROBERT · 2012 to 2015
–
BLRD VA I01 BX001496BLRD VA I01 BX003212NIAMS NIH HHS P30 AR066262NIDDK NIH HHS R01 DK072071
6 · The paper itself

Abstract

Age-related bone loss is an important risk factor for fractures in the elderly; it results from an imbalance in bone remodeling mainly due to decreased bone formation. We have previously demonstrated that endogenous G protein-coupled receptor (GPCR)-driven Gi signaling in osteoblasts (Obs) restrains bone formation in mice during growth. Here, we launched a longitudinal study to test the hypothesis that Gi signaling in Obs restrains bone formation in aging mice, thereby promoting bone loss. Our approach was to block Gi signaling in maturing Obs by the induced expression of the catalytic subunit of pertussis toxin (PTX) after the achievement of peak bone mass. In contrast to the progressive cancellous bone loss seen in aging sex-matched littermate control mice, aging female Col1(2.3)+/PTX+ mice showed an age-related increase in bone volume. Increased bone volume was associated with increased bone formation at both trabecular and endocortical surfaces as well as increased bending strength of the femoral middiaphyses. In contrast, male Col1(2.3)+/PTX+ mice were not protected from age-related bone loss. Our results indicate that Gi signaling markedly restrains bone formation at cancellous and endosteal bone surfaces in female mice during aging. Blockade of the relevant Gi-coupled GPCRs represents an approach for the development of osteoporosis therapies-at least in the long bones of aging women.

Indexed as

AnimalsBone DensityBone RemodelingCollagen Type ICollagen Type I, alpha 1 ChainFemaleGTP-Binding Protein alpha Subunits, Gi-GoMaleMiceMice, TransgenicOsteoblastsOsteogenesisOsteoporosisPertussis ToxinSignal TransductionCollagen Type ICollagen Type I, alpha 1 ChainGTP-Binding Protein alpha Subunits, Gi-GoPertussis Toxin

Identifiers

PMID28407060
PMCPMC5460929
OpenAlexW2606981641

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.